A Win For Miragen Therapeutics
Wed, Oct 28, 2020 at 05:30 PM
Miragen Therapeutics (MGEN:NASDAQ) shot up at $1.26, a gain of 142.4%. The stock got featured on our News Catalysts scanner on Wed 28 Oct 20 at 10:23 AM in the 'ACQUISITION' category. From Tue 13 Oct 20, the stock recorded 20.00% Up Days and 0.00% Green Days
The stock spiked on Fri 24 Jul 20 at $1.61 with a volume of 44M+, and its share price has been moving sideways in recent weeks.
About Miragen Therapeutics (MGEN:NASDAQ)
Miragen Therapeutics Inc is a clinical-stage biopharmaceutical company which engaged in discovering and developing proprietary RNA (Ribonucleic acid)-targeted therapeutics.
Top 10 Gainers:
- Miragen Therapeutics (MGEN:NASDAQ), 142.35%
- Scholar Rock Holding Corporation (SRRK:NASDAQ), 44.67%
- Tupperware Brands Corporation (TUP:NYSE), 35.08%
- Community Health Systems, Inc. (CYH:NYSE), 30.07%
- Titan Pharmaceuticals, Inc. (TTNP:NASDAQ), 29.88%
- AUVI (AUVI:NASDAQ), 27.79%
- Civeo Corporation (CVEO:NYSE), 26.41%
- Sino-Global Shipping America, Ltd. (SINO:NASDAQ), 22.7%
- Socket Mobile, Inc. (SCKT:NASDAQ), 22.22%
- IKONICS Corporation (IKNX:NASDAQ), 17.79%